This biotech innovator in inhaled therapeutics reported a notable insider sale amid ongoing product development and licensing activity.

Reflecting on her statement, consultant dietitian and diabetes educator Kanikka Malhotra said it offers a vivid snapshot of ...

Gandhinagar: About 17,000 children in the state suffer from Type-1 diabetes (T1D) and require regular insulin administration.

About 14% of adults in Philadelphia have diabetes, one of the highest rates in the country, the city said, and Black and ...

Are there ingredients in sugar-free desserts that aren’t as healthy as they seem? Amber Raiken speaks to dietitians about ...

Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of ...

Different blood sugar medications can cause different side effects. Learn more about some of the serious possible side effects of common diabetes medications here.

Former senator Ben Sasse announced his stage 4 pancreatic cancer diagnosis in 2025, calling it "a death sentence" while ...

The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...

Habits can be changed, our bodies can get used to these things quite quickly, and small changes can make a big difference ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year.

On Dec. 23, 2025, investors weighed a newly approved oral obesity pill’s first-mover edge and its ripple effects across healthcare.